Stewart Murray 4
4 · X4 Pharmaceuticals, Inc · Filed Aug 11, 2023
Insider Transaction Report
Form 4
Stewart Murray
Director
Transactions
- Award
Common Stock
2023-08-09+269,893→ 276,560 total - Sale
Common Stock
2023-08-10$1.06/sh−130,056$137,859→ 146,504 total
Footnotes (3)
- [F1]Represents shares of common stock acquired upon acceleration of the vesting of a performance-based restricted stock unit grant.
- [F2]Represents nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the settlement of restricted stock units.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.02 to $1.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.